Hi everyone,
I currently have the gene expression matrix for mouse scRNA-seq bladder samples in WT vs KO conditions. These samples contain a mixture of normal (immune & bladder cells) and tumor cells. I have carried out the standard quality-control, normalisation, dimensional reduction and integration steps with Seurat v4.0.6. My question here is: how can I identify the tumor vs normal cells in the scRNA-seq dataset apart from one another?
I currently have 2 ideas:
Obtain the marker genes for the clusters and then have experts identify which clusters correspond to normal cells and which are likely the tumors. I can also perform automated cell-type annotation (e.g. reference-based annotation) against age-matched reference mouse bladder samples, which will help to narrow down the clusters that correspond to normal tissue samples, leaving the remainder as likely candidates for tumor-cell containing clusters.
Identify tumor cells as cells that have CNV. Identify CNVs using tools like honeybadger & inferCNV, and based on that, probabilistically label cells as tumor / normal.
I would appreciate your suggestions on the matter, as well as references to papers that have performed similar analysis. Thank you for reading!
1 answer
Hello,
You can do both. Check for common marker genes first, and then test cells for CNV. I would also recommend that you check out the latest tools for CNV recognition, as Identifying tumor cells at the single-cell level using machine learning
Log in to answer this question.
You could also check the mitochondrial variants to potentially identify the cancer clone:
http://www.bioconductor.org/packages/release/bioc/html/mitoClone2.html